Read transcripts of debates in both Houses
Produced by Commons Library, Lords Library and Parliamentary Office Science and Technology
Search for Members by name, postcode, constituency and party
Learn about their experience, knowledge and interests
Celebrating people who have made Parliament a positive, inclusive working environment
Four staff networks for people to discuss and consider issues.
Contact your MP or a Member of the House of Lords about an issue that matters to you
Sign up for the Your Parliament newsletter to find out how you can get involved
Take a tour of Parliament and enjoy a delicious afternoon tea by the River Thames
See some of the sights you’ll encounter on a tour of Parliament
Book a school visit, classroom workshop or teacher-training session
Access videos, worksheets, lesson plans and games
Follow this EDM by:
That this House notes with concern the recent refusal by the Minister for Care and Support of a public inquiry into why information was withheld concerning the disastrous way in which sodium valproate has affected pregnant women and their children; further notes the cost to the public purse of additional health, education and welfare costs incurred by families affected by Fetal Valproate Syndrome; believes that the regulator could have avoided such costs and large numbers of people affected since sodium valproate was licensed and sold from 1973; further believes that its makers, the pharmaceutical company Sanofi, failed in its duty of care and corporate responsibility by not informing the relevant agencies of its teratogenic effects; welcomes the Minister's recent decision to meet representatives of the Independent Fetal Anti-Convulsant Trust; and urges the holding of a public inquiry.
Total number of signatures: 28
Showing 28 out of 28